Literature DB >> 33515256

Laboratory Action Plan for Emerging SARS-CoV-2 Variants.

Laura Filkins1,2, Jeffrey A SoRelle1,2, John Schoggins3, Jason Y Park1,2,4.   

Abstract

Entities:  

Keywords:  B.1.1.7; COVID-19; SARS-CoV-2; VOC-202012/01; VUI-202012/01; coronavirus disease 2019

Mesh：

Year:  2021        PMID： 33515256      PMCID： PMC7929022          DOI： 10.1093/clinchem/hvab020

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.

Authors:  Antonin Bal; Gregory Destras; Alexandre Gaymard; Karl Stefic; Julien Marlet; Sébastien Eymieux; Hadrien Regue; Quentin Semanas; Constance d'Aubarede; Geneviève Billaud; Frédéric Laurent; Claudia Gonzalez; Yahia Mekki; Martine Valette; Maude Bouscambert; Catherine Gaudy-Graffin; Bruno Lina; Florence Morfin; Laurence Josset
Journal:  Euro Surveill       Date:  2021-01

2.  Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.

Authors:  Kevin R McCarthy; Linda J Rennick; Sham Nambulli; Lindsey R Robinson-McCarthy; William G Bain; Ghady Haidar; W Paul Duprex
Journal:  Science       Date:  2021-02-03       Impact factor: 47.728

3.  Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.

Authors:  Victoria A Avanzato; M Jeremiah Matson; Stephanie N Seifert; Rhys Pryce; Brandi N Williamson; Sarah L Anzick; Kent Barbian; Seth D Judson; Elizabeth R Fischer; Craig Martens; Thomas A Bowden; Emmie de Wit; Francis X Riedo; Vincent J Munster
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

4.  Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.

Authors:  Bina Choi; Manish C Choudhary; James Regan; Jeffrey A Sparks; Robert F Padera; Xueting Qiu; Isaac H Solomon; Hsiao-Hsuan Kuo; Julie Boucau; Kathryn Bowman; U Das Adhikari; Marisa L Winkler; Alisa A Mueller; Tiffany Y-T Hsu; Michaël Desjardins; Lindsey R Baden; Brian T Chan; Bruce D Walker; Mathias Lichterfeld; Manfred Brigl; Douglas S Kwon; Sanjat Kanjilal; Eugene T Richardson; A Helena Jonsson; Galit Alter; Amy K Barczak; William P Hanage; Xu G Yu; Gaurav D Gaiha; Michael S Seaman; Manuela Cernadas; Jonathan Z Li
Journal:  N Engl J Med       Date:  2020-11-11       Impact factor: 91.245

Review 5.  Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.

Authors:  Fran Robson; Khadija Shahed Khan; Thi Khanh Le; Clément Paris; Sinem Demirbag; Peter Barfuss; Palma Rocchi; Wai-Lung Ng
Journal:  Mol Cell       Date:  2020-08-04       Impact factor: 17.970

6.  Low genetic diversity may be an Achilles heel of SARS-CoV-2.

Authors:  Jason W Rausch; Adam A Capoferri; Mary Grace Katusiime; Sean C Patro; Mary F Kearney
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205
  6 in total
  1 in total

1.  Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern.

Authors:  Andrew E Clark; Zhaohui Wang; Emily Ostman; Hui Zheng; Huiyu Yao; Brandi Cantarel; Mohammed Kanchwala; Chao Xing; Li Chen; Pei Irwin; Yan Xu; Dwight Oliver; Francesca M Lee; Jeffrey R Gagan; Laura Filkins; Alagarraju Muthukumar; Jason Y Park; Ravi Sarode; Jeffrey A SoRelle
Journal:  Clin Chem       Date:  2022-07-27       Impact factor: 12.167
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.